WallStreetZenWallStreetZen

NASDAQ: CRSP
Crispr Therapeutics Ag Stock Ownership - Who owns Crispr Therapeutics Ag?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Crispr Therapeutics Ag insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Samarth KulkarniCEO2026-10-1947,837$49.78
$2.38MSell
Samarth KulkarniCEO2026-10-144,098$49.26
$201.87kSell
Simeon GeorgeDirector2026-10-1430,000$14.00
$420.00kBuy
Simeon GeorgeDirector2026-10-1414,514$49.63
$720.37kSell
James R. KasingerCLO;Sec2026-10-141,040$49.26
$51.23kSell
James R. KasingerCLO;Sec2026-10-061,990$13.62
$27.10kBuy
James R. KasingerCLO;Sec2026-10-061,990$60.04
$119.48kSell
James R. KasingerCLO;Sec2026-09-2210,400$13.62
$141.65kBuy
James R. KasingerCLO;Sec2026-09-2210,400$60.24
$626.45kSell
Ali BehbahaniDirector2026-09-1730,000$14.00
$420.00kBuy

1 of 4

CRSP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRSP insiders and whales buy or sell their stock.

CRSP Shareholders

What type of owners hold Crispr Therapeutics Ag stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Celgene Corp8.85%8,557,514$440.03MInsider
Simeon George5.77%5,583,460$287.10MInsider
Vertex Pharmaceuticals Europe Ltd5.56%5,380,940$276.69MInsider
Bayer Global Investments Bv5.28%5,105,330$262.52MInsider
Glaxosmithkline PLC3.33%3,220,627$165.60MInsider
Kurt Von Emster2.60%2,516,786$129.41MInsider
Sven Ante Lundberg1.05%1,010,834$51.98MInsider
Hadley Harbor Master Investors Cayman LP0.77%744,380$38.28MInsider
Thomas Woiwode0.67%645,643$33.20MInsider
Rodger Novak0.59%573,007$29.46MInsider

1 of 3

CRSP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRSP0.08%36.03%Net SellingNet Selling
ERAS0.08%24.59%Net Buying
TVTX0.11%61.52%Net SellingNet Selling
DNTH0.12%60.34%Net BuyingNet Buying
PTCT0.12%18.81%Net SellingNet Selling
View Top Biotech Stocks

Crispr Therapeutics Ag Stock Ownership FAQ

Who owns Crispr Therapeutics Ag?

Crispr Therapeutics Ag (NASDAQ: CRSP) is owned by 0.08% institutional shareholders, 36.03% Crispr Therapeutics Ag insiders, and 63.89% retail investors. Celgene Corp is the largest individual Crispr Therapeutics Ag shareholder, owning 8.56M shares representing 8.85% of the company. Celgene Corp's Crispr Therapeutics Ag shares are currently valued at $427.79M.

If you're new to stock investing, here's how to buy Crispr Therapeutics Ag stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.